Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres
- PMID: 10467365
- DOI: 10.1038/sj.gt.3300954
Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres
Abstract
Patterns of dystrophin and beta-galactosidase expression were examined in mdx mice after i.m. injections of synthetic microspheres (MF-2) loaded with full-length (pHSADy) or mini-dystrophin gene (pSG5dys) cDNA plasmid constructs or with LacZ marker gene (pCMV-LacZ). A single injection of 25 microg pHSADy into quadriceps femoris muscle resulted in 6.8% of dystrophin positive myofibers (DPM) in a given muscle; 8.4% of DPM in glutaeus muscle and 4.3% of DPM in quadriceps femoris muscle of contralateral limb on day 21 after exposure compared with only 0.6% DPM in intact (non-injected) mdx mice. A high proportion of DPM (17.6% and 10.8%, respectively) was registered in both injected and contralateral muscles after mini- gene cDNA administration. MF-2/dystrophin cDNA particles were detected by FISH analysis in about 60-70% of myofiber nuclei in muscles of injected and contralateral limbs 7 days after application. The presence of human dystrophin cDNA and its products in all skeletal muscles and in different internal organs was proven by PCR and RT-PCR analysis. Patches of beta-galactosidase expression were abundant in injected muscle, and frequent in the contralateral and other skeletal muscles as well as in diaphragm, heart and lungs. High levels of dystrophin cDNA expression, and an efficient distant transfection effect with preferential intranuclei inclusion of MF-2 vehicle, are very encouraging for the development of a new constructive strategy in gene therapy trials of DMD.
Similar articles
-
[Features of transfection and expression of cDNA for the human dystrophin gene, delivered into muscles of mdx mice using MF-2 synthetic microspheres].Genetika. 1999 Jan;35(1):22-7. Genetika. 1999. PMID: 10330608 Russian.
-
Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation.Muscle Nerve. 2003 Feb;27(2):237-41. doi: 10.1002/mus.10283. Muscle Nerve. 2003. PMID: 12548532
-
[Expression of the human dystrophin gene in mdx mouse muscle fibers after transfection using liposomes and synthetic oligopeptides].Genetika. 1998 Jul;34(7):876-82. Genetika. 1998. PMID: 9749328 Russian.
-
The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.Muscle Nerve. 1993 Nov;16(11):1141-53. doi: 10.1002/mus.880161102. Muscle Nerve. 1993. PMID: 8413366 Review.
-
[Current status and perspective of gene therapy on dystrophic animal model].Rinsho Shinkeigaku. 2004 Nov;44(11):911-3. Rinsho Shinkeigaku. 2004. PMID: 15651329 Review. Japanese.
Cited by
-
Polymers for DNA delivery.Molecules. 2005 Jan 31;10(1):34-64. doi: 10.3390/10010034. Molecules. 2005. PMID: 18007276 Free PMC article. Review.
-
Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.J Control Release. 2006 May 1;112(1):120-8. doi: 10.1016/j.jconrel.2006.01.013. Epub 2006 Mar 10. J Control Release. 2006. PMID: 16530876 Free PMC article.
-
Progress in gene therapy for Duchenne muscular dystrophy.Curr Neurol Neurosci Rep. 2001 Jan;1(1):89-96. doi: 10.1007/s11910-001-0080-0. Curr Neurol Neurosci Rep. 2001. PMID: 11898504 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources